News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Jenna R. Carl, PhD

Dr Carl is vice president of clinical development & medical affairs at Big Health Inc.

Articles by Jenna R. Carl, PhD

Issues in Regulating DTx

ByBrian D. Doss, PhD,Kenneth R. Weingardt, PhD,Oliver J. Lindhiem, PhD,Adela C. Timmons, PhD,Deborah J. Jones, PhD,Jonathan S. Comer, PhD,Jenna R. Carl, PhD

August 10th 2021

We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?

Latest Updated Articles

Trending on Psychiatric Times

Whatever Happened to Psychopathology?

Yale Expertise in Pain, Trauma Techniques Help Ukrainian MDs During Month-Long Training

The “No Kings” Rallies: Tricks or Treats?

Who Should Avoid Halloween Tricks and Treats?

How Can Chatbots Be Made Safe for Psychiatric Patients

© 2025 MJH Life Sciences^®

All rights reserved.